Summary

Report Summary

Karo Healthcare AB Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Karo Healthcare AB 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Karo Healthcare AB including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Karo Healthcare AB's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Karo Healthcare AB's overall strategic standing and supports informed decision-making and strategic planning.

Finally, the report includes recent news and deal activities undertaken by Karo Healthcare AB enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Karo Healthcare AB, established in 1987 and headquartered in Stockholm, Sweden, is a leading healthcare company dedicated to providing “Smart Choices for Everyday Healthcare.” With a mission to empower individuals to take control of their daily health, Karo focuses on addressing, treating, and preventing common health-related issues, enhancing quality of life beyond avoiding serious illness or hospitalization. The company operates with a consumer-centric vision, combining responsible growth, innovation, and strategic brand management to create lasting value for people and society. Karo owns and commercializes a portfolio of trusted branded products and medicines across key everyday healthcare categories. Its offerings are available in more than 90 countries, with Europe and the Nordic region as core markets. In 2023, the company launched 150 new products, supporting revenue exceeding €500 million. The workforce comprises approximately 460 employees across 13 countries, representing over 40 nationalities, with 46 percent of senior leadership roles held by women, reflecting Karo’s commitment to diversity and inclusion. The company follows a Scaled Entrepreneurship model, empowering cross-functional squads to lead specific brands or categories, fostering innovation and collective intelligence. Karo also emphasizes sustainability and social responsibility, partnering with organizations like Operation Smile to improve global healthcare outcomes. Through its global presence, strategic innovation, and consumer-focused approach, Karo Healthcare AB continues to expand its influence in everyday healthcare markets worldwide.

Karo Healthcare AB in the News:-

2025-04-09 - Karo Healthcare announces KKR as new owner, following successful strategic transformation into pan-European consumer healthcare player
2024-09-11 - Karo Healthcare appoints Egil Molsted Madsen as CFO


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Karo Healthcare AB's internal and external factors through SWOT analysis and Corporate Strategy.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Karo Healthcare AB:

• Karo Healthcare AB PESTLE Analysis
• Karo Healthcare AB Value Chain Analysis
• Karo Healthcare AB Porter's Five Forces Analysis
• Karo Healthcare AB VRIO Analysis
• Karo Healthcare AB BCG Analysis
• Karo Healthcare AB Segmentation, Targeting and Positioning (STP) Analysis
• Karo Healthcare AB Ansoff Matrix Analysis

ページTOPに戻る

Table of Contents

Tables 5
Charts 6
Karo Healthcare AB - Key Company Facts 7
Karo Healthcare AB - Company Description 8
Karo Healthcare AB - Top Executives 9
Karo Healthcare AB - Head Office & Locations 10
Head Office - Country 10
Karo Healthcare AB - Products and Services 11
Products 11
Services 12
Karo Healthcare AB - Corporate Strategy 13
Karo Healthcare AB - Business Description 16
Skin Health 16
Intimate Health 17
Digestive Health 17
Foot Health 17
Vitamins and Mineral Supplements 18
Karo Healthcare AB - ESG Spotlight 19
Environment 19
Social 20
Corporate Governance 20
Karo Healthcare AB - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 26
Threats 28
Competing Players 30
Snapshot of Competing Players 31
Bayer Aktiengesellschaft (Bayer AG) 31
Key Company Facts 31
Company Description 31
Bayer Aktiengesellschaft (Bayer AG) - SWOT Spotlight 32
Bayer Aktiengesellschaft (Bayer AG) - PESTLE Spotlight 34
Key Financials 36
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 36
Key Financial Ratio Analysis 41
Beiersdorf AG 43
Key Company Facts 43
Company Description 43
Key Financials 44
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 44
Key Financial Ratio Analysis 49
BioInvent International AB 51
Key Company Facts 51
Company Description 51
Key Financials 52
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 52
Key Financial Ratio Analysis 57
Genmab A/S 59
Key Company Facts 59
Company Description 59
Key Financials 60
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 60
Key Financial Ratio Analysis 65
Reckitt Benckiser Group Plc 67
Key Company Facts 67
Company Description 67
Reckitt Benckiser Group Plc - SWOT Spotlight 68
Reckitt Benckiser Group Plc - PESTLE Spotlight 70
Key Financials 72
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 72
Key Financial Ratio Analysis 77
Karo Healthcare AB - In the News 79
09-Apr-2025- Karo Healthcare announces KKR as new owner, following successful strategic transformation into pan-European consumer healthcare player 79
11-Sep-2024- Karo Healthcare appoints Egil Molsted Madsen as CFO 81
Karo Healthcare AB - Key Deals 82
06-Mar-2024 - Karo Healthcare expands its presence in Italy with the acquisition of the rights to Proctosedyl from Bayer 82
Appendix 83
Definitions 83
SWOT Analysis 83
PESTLE Analysis 83
Value Chain Analysis 83
ESG Spotlight 83
Research Methodology 84
Disclaimer 85
Contact Us 85